Loading…
Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam
Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and...
Saved in:
Published in: | Journal of analytical toxicology 2001-07, Vol.25 (5), p.316-322 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93 |
---|---|
cites | |
container_end_page | 322 |
container_issue | 5 |
container_start_page | 316 |
container_title | Journal of analytical toxicology |
container_volume | 25 |
creator | El-Haj, B.M. Al-Amri, A.M. Hassan, M.H. Bin-Khadem, R.K. |
description | Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP. |
doi_str_mv | 10.1093/jat/25.5.316 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18248039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jat/25.5.316</oup_id><sourcerecordid>18248039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93</originalsourceid><addsrcrecordid>eNqF0M9P2zAYx2ELbRod223nyYeJXZrg33GOUDGo1IpDS4e4WI7toEASBzuZxv56UloNbpx8efR95Q8A3zBKMcrpyb3uTwhPeUqxOAATnDOeEIboBzBBmImEZQIdgs8x3iOEhRT0EzjEmOW5lGwCfs_bPy721Z3uK9_Cedt7uPKNg6exc6aP0JfwfDlfQ5vqdEincL2YTaFuLbyYJcsVvA5Vq-unWL3Is-Ab_c91uvkCPpa6ju7r_j0C17_O17PLZHF1MZ-dLhLDCOsTQaTQuLAiszgjeWGLzBLhsMMlLxwTXGZSWFmWCBPEiXVGl9Qak2uDiCtyegSOd7td8I_D-BPVVNG4utat80NUWBImEd3C6Q6a4GMMrlRdqBodnhRGahtSjSEV4YqrMeTIv-93h6Jx9hXvy43gxx7oaHRdBt2aKr4ZlSzPtuznjvmhe-9ispNV7N3f_1aHByUymnF1eXOr1nyzWcqbldrQZ3i2lYM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18248039</pqid></control><display><type>article</type><title>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>El-Haj, B.M. ; Al-Amri, A.M. ; Hassan, M.H. ; Bin-Khadem, R.K.</creator><creatorcontrib>El-Haj, B.M. ; Al-Amri, A.M. ; Hassan, M.H. ; Bin-Khadem, R.K.</creatorcontrib><description>Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.</description><identifier>ISSN: 0146-4760</identifier><identifier>EISSN: 1945-2403</identifier><identifier>DOI: 10.1093/jat/25.5.316</identifier><identifier>PMID: 11499884</identifier><identifier>CODEN: JATOD3</identifier><language>eng</language><publisher>Niles, IL: Oxford University Press</publisher><subject>Analysis ; Biological and medical sciences ; bromazepam ; Bromazepam - analogs & derivatives ; Bromazepam - analysis ; Bromazepam - metabolism ; Bromazepam - urine ; Chromatography, Thin Layer ; Enzyme Multiplied Immunoassay Technique ; Gas Chromatography-Mass Spectrometry ; General pharmacology ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Substance Abuse Detection - methods</subject><ispartof>Journal of analytical toxicology, 2001-07, Vol.25 (5), p.316-322</ispartof><rights>2001</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,777,781,786,787,23911,23912,25121,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1084974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11499884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El-Haj, B.M.</creatorcontrib><creatorcontrib>Al-Amri, A.M.</creatorcontrib><creatorcontrib>Hassan, M.H.</creatorcontrib><creatorcontrib>Bin-Khadem, R.K.</creatorcontrib><title>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</title><title>Journal of analytical toxicology</title><addtitle>Journal of Analytical Toxicology</addtitle><addtitle>Journal of Analytical Toxicology</addtitle><description>Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>bromazepam</subject><subject>Bromazepam - analogs & derivatives</subject><subject>Bromazepam - analysis</subject><subject>Bromazepam - metabolism</subject><subject>Bromazepam - urine</subject><subject>Chromatography, Thin Layer</subject><subject>Enzyme Multiplied Immunoassay Technique</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Substance Abuse Detection - methods</subject><issn>0146-4760</issn><issn>1945-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqF0M9P2zAYx2ELbRod223nyYeJXZrg33GOUDGo1IpDS4e4WI7toEASBzuZxv56UloNbpx8efR95Q8A3zBKMcrpyb3uTwhPeUqxOAATnDOeEIboBzBBmImEZQIdgs8x3iOEhRT0EzjEmOW5lGwCfs_bPy721Z3uK9_Cedt7uPKNg6exc6aP0JfwfDlfQ5vqdEincL2YTaFuLbyYJcsVvA5Vq-unWL3Is-Ab_c91uvkCPpa6ju7r_j0C17_O17PLZHF1MZ-dLhLDCOsTQaTQuLAiszgjeWGLzBLhsMMlLxwTXGZSWFmWCBPEiXVGl9Qak2uDiCtyegSOd7td8I_D-BPVVNG4utat80NUWBImEd3C6Q6a4GMMrlRdqBodnhRGahtSjSEV4YqrMeTIv-93h6Jx9hXvy43gxx7oaHRdBt2aKr4ZlSzPtuznjvmhe-9ispNV7N3f_1aHByUymnF1eXOr1nyzWcqbldrQZ3i2lYM</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>El-Haj, B.M.</creator><creator>Al-Amri, A.M.</creator><creator>Hassan, M.H.</creator><creator>Bin-Khadem, R.K.</creator><general>Oxford University Press</general><general>Preston</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20010701</creationdate><title>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</title><author>El-Haj, B.M. ; Al-Amri, A.M. ; Hassan, M.H. ; Bin-Khadem, R.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>bromazepam</topic><topic>Bromazepam - analogs & derivatives</topic><topic>Bromazepam - analysis</topic><topic>Bromazepam - metabolism</topic><topic>Bromazepam - urine</topic><topic>Chromatography, Thin Layer</topic><topic>Enzyme Multiplied Immunoassay Technique</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Substance Abuse Detection - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El-Haj, B.M.</creatorcontrib><creatorcontrib>Al-Amri, A.M.</creatorcontrib><creatorcontrib>Hassan, M.H.</creatorcontrib><creatorcontrib>Bin-Khadem, R.K.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of analytical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El-Haj, B.M.</au><au>Al-Amri, A.M.</au><au>Hassan, M.H.</au><au>Bin-Khadem, R.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam</atitle><jtitle>Journal of analytical toxicology</jtitle><stitle>Journal of Analytical Toxicology</stitle><addtitle>Journal of Analytical Toxicology</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>25</volume><issue>5</issue><spage>316</spage><epage>322</epage><pages>316-322</pages><issn>0146-4760</issn><eissn>1945-2403</eissn><coden>JATOD3</coden><abstract>Among the different 1,4-benzodiazepine urinary metabolites, those of bromazepam possess distinctive chemical features that may be used in their selective isolation and detection. The detection of bromazepam metabolites in urine was carried out using EMIT d.a.u., thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS). The positive EMIT d.a.u. benzodiazepine assay for bromazepam was found to be due to the 3-hydroxybromazepam (3HOB) metabolite. The detection by TLC and GC-MS was carried out after enzyme or acid hydrolysis of the glucuronide conjugates. Both the 2-amino-3-hydroxy-5-bromobenzoylpyridine (AHBBP) metabolite and the acid hydrolysis product of 3-HOB, 2-amino-5-bromobenzoylpyridine (ABBP), were selectively detected by TLC. The bromazepam metabolites in urine could be both isolated and detected selectively by GC-MS in the presence of the metabolites of other 1,4-benzodiazepines that were sometimes used in combination with bromazepam. Both 3-HOB and AHBBP were detected by GC-MS only after trimethylsilyl (TMS) derivatization and not as the free compounds or the acetyl derivatives. Only ABBP was detected in three forms: ABBP, the TMS derivative, and the acetyl derivative. Evidence has been obtained from the enzyme hydrolysis and the TLC studies for the formation of the glucuronide conjugate of AHBBP at the 3-OH group rather than at the 2-NH2 group. All the results have been validated using reference 3-HOB and AHBBP.</abstract><cop>Niles, IL</cop><pub>Oxford University Press</pub><pmid>11499884</pmid><doi>10.1093/jat/25.5.316</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0146-4760 |
ispartof | Journal of analytical toxicology, 2001-07, Vol.25 (5), p.316-322 |
issn | 0146-4760 1945-2403 |
language | eng |
recordid | cdi_proquest_miscellaneous_18248039 |
source | Oxford Journals Online; Alma/SFX Local Collection |
subjects | Analysis Biological and medical sciences bromazepam Bromazepam - analogs & derivatives Bromazepam - analysis Bromazepam - metabolism Bromazepam - urine Chromatography, Thin Layer Enzyme Multiplied Immunoassay Technique Gas Chromatography-Mass Spectrometry General pharmacology Humans Medical sciences Pharmacology. Drug treatments Substance Abuse Detection - methods |
title | Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC-MS Urinalysis of Bromazepam |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigation%20Into%20Some%20Aspects%20of%20EMIT%20d.a.u.,%20TLC,%20and%20GC-MS%20Urinalysis%20of%20Bromazepam&rft.jtitle=Journal%20of%20analytical%20toxicology&rft.au=El-Haj,%20B.M.&rft.date=2001-07-01&rft.volume=25&rft.issue=5&rft.spage=316&rft.epage=322&rft.pages=316-322&rft.issn=0146-4760&rft.eissn=1945-2403&rft.coden=JATOD3&rft_id=info:doi/10.1093/jat/25.5.316&rft_dat=%3Cproquest_cross%3E18248039%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c424t-6286a1bd67d1729bdb7d26e1e1f5be4658786d8ff012052decaf3dcc9ac02eb93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18248039&rft_id=info:pmid/11499884&rft_oup_id=10.1093/jat/25.5.316&rfr_iscdi=true |